Elionova Is Revolutioninzing the Rapid Testing Market
ELIONOVA, located at BlueFactory, site of SIP West EPFL is revolutionizing the rapid testing market, offering an innovative diagnostic platform and in...
More details More detailsIchnos Sciences Joins Site Biopôle of SIP West EPFL
Ichnos Sciences is the latest addition to Biopôle’s growing corporate network. This collaboration combines Biopôle’s diverse and ambitious life sciences...
More detailsStartfeld Becomes Part of Switzerland Innovation Park Ost
Startfeld and Switzerland Innovation Park Ost are merging with immediate effect. The respective boards approved the merger on June 15. With the merger,...
More detailsAkselos to Accelerate Large Scale Deployment of Renewable Energy
Akselos, leader in physics-based Digital Twins based at EPFL Innovation Park, site of SIP West EPFL, simulates exact virtual replicas, or predictive and...
More detailsEPFL Innovation Park Turns 30
Past, present and future: discover how EPFL Innovation Park, site of SIP West EPFL, has given way to success and the new vision of innovation for the next...
More detailsINNOVATICA 2022 - Experience Innovation at the SIP Zurich
Erleben Sie an der Erlebnisschau INNOVATICA 2022 hautnah spannende Innovations- und Forschungsprojekte, wenn der Innovationspark Zürich am Samstag, 11....
More detailsCircular Building Industry Booster Team Launched its 2nd Project Call
Do you have a project idea that increases circularity in the building sector? Submit your project idea by September 2, 2022, and convince our jury, of...
More detailsAllthisfuture Launched Its Project Call “Intelligence or Copper?”
Project ideas wanted! WWZ Innovation Lab based at Park Central, Site of SIP Zurich, searches for new intelligent tools and business ideas to make grid...
More detailsUpcycling Workshop at Bluefactory Fribourg
During a constructive second-hand, upcycling workshop at BlueFactory Fribourg, site of Switzerland Innovation Park West EPFL, directed by the EPFL Structural...
More detailsEngimmune Therapeutics Drives Forward T-Cell Therapies Against Cancer
Engimmune Therapeutics drives forward its innovative platforms for the development of T-cell therapies against cancer after receiving seed financing to...
More detailsACROBiosystems Establishes Presence at the SIP Basel Area
ACROBiosystems AG, a company operating in the US and in Asia, has selected the Switzerland Innovation Park Basel Area for its first European location....
More detailsHans Ebinger Becomes CEO of Switzerland Innovation Park Ost
As of April 1st, 2022, Dr. Hans Ebinger will take over as CEO of the SIP Ost. His task will be to develop the innovation park into a platform that sustainably...
More details